EU Drug Watchdog Approves AstraZeneca Covid Prevention Jab ‘Evusheld’
A photo taken on February 8, 2022 shows a box of Evusheld, a drug for antibody therapy developed by AstraZeneca for the prevention of COVID-19 in immunocompromised patients at the AstraZeneca facility for biological medicines in Södertälje, south of Stockholm, Sweden. (AFP)The European Medicines Agency’s human medicines committee has recommended granting a marketing authorisation for…Continue Reading
